TY - JOUR
T1 - Understanding the relationship between sales of legal cigarettes and deaths
T2 - A case-study in Brazil
AU - Szklo, André Salem
AU - Iglesias, Roberto Magno
AU - de Souza, Mirian Carvalho
AU - Szklo, Moysés
AU - Cavalcante, Tânia Maria
AU - de Almeida, Liz Maria
N1 - Funding Information:
The GATS-Brazil survey conducted in 2013 was funded by the Brazilian Ministry of Health. The funder had no direct involvement in the analysis and interpretation of the data as well as in the writing of the report and in the decision to submit the paper.
Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Brazil has experienced a large decline in cigarette consumption in the last 25 years. However, the most recent annual reports from the tobacco industry market leader in Brazil did not show a decrease in its gross profits. This is particularly important because tobacco industry donations/sponsorships come directly from the industry's reported gross-profits and are used to subvert health policies. The aim of the present study was to estimate (i) tobacco industry's gross-profit from legal cigarettes sales, and (ii) all-cause smoking-attributable deaths (SADs) among current Brazilian smokers who consumed legal cigarettes in 2013. We collected information on prevalence of legal cigarette use, cigarette consumption, price per cigarette pack among individuals aged ≥ 35 years from the Global Adult Tobacco Survey, legal cigarettes sales (e.g., average costs and total volume of sales) provided by the Federal Secretariat of Revenues, and population mortality from the available vital statistics. With a gross-profit of US$1.378 billion (1.307–1.434) from sales of 54.6 billion sticks of cigarettes (53.4–55.5) to 8,424,510 smokers aged 35 years and older in Brazil in 2013, cumulative SADs were estimated at 96,012 (85,647–107,654) (around 34% of cumulative SADs also including current smoking of illegal cigarettes and past smoking), i.e., one SAD was equivalent to a gross-profit of US$14,352 (12,140–16,743). Our results revealed the association between sales of cigarettes, gross-profits, and deaths in Brazil. As tobacco industry donations/sponsorships originate from industry's gross profits, which, in turn, depend on cigarette sales, our findings may be useful for increasing “moral pressure” on individuals and institutions and help countries in stopping tobacco industry interference in health policies.
AB - Brazil has experienced a large decline in cigarette consumption in the last 25 years. However, the most recent annual reports from the tobacco industry market leader in Brazil did not show a decrease in its gross profits. This is particularly important because tobacco industry donations/sponsorships come directly from the industry's reported gross-profits and are used to subvert health policies. The aim of the present study was to estimate (i) tobacco industry's gross-profit from legal cigarettes sales, and (ii) all-cause smoking-attributable deaths (SADs) among current Brazilian smokers who consumed legal cigarettes in 2013. We collected information on prevalence of legal cigarette use, cigarette consumption, price per cigarette pack among individuals aged ≥ 35 years from the Global Adult Tobacco Survey, legal cigarettes sales (e.g., average costs and total volume of sales) provided by the Federal Secretariat of Revenues, and population mortality from the available vital statistics. With a gross-profit of US$1.378 billion (1.307–1.434) from sales of 54.6 billion sticks of cigarettes (53.4–55.5) to 8,424,510 smokers aged 35 years and older in Brazil in 2013, cumulative SADs were estimated at 96,012 (85,647–107,654) (around 34% of cumulative SADs also including current smoking of illegal cigarettes and past smoking), i.e., one SAD was equivalent to a gross-profit of US$14,352 (12,140–16,743). Our results revealed the association between sales of cigarettes, gross-profits, and deaths in Brazil. As tobacco industry donations/sponsorships originate from industry's gross profits, which, in turn, depend on cigarette sales, our findings may be useful for increasing “moral pressure” on individuals and institutions and help countries in stopping tobacco industry interference in health policies.
KW - Health policy
KW - Smoking
KW - Tobacco industry
UR - http://www.scopus.com/inward/record.url?scp=85003845702&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85003845702&partnerID=8YFLogxK
U2 - 10.1016/j.ypmed.2016.11.008
DO - 10.1016/j.ypmed.2016.11.008
M3 - Article
C2 - 27856337
AN - SCOPUS:85003845702
SN - 0091-7435
VL - 94
SP - 55
EP - 59
JO - Preventive Medicine
JF - Preventive Medicine
ER -